Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognosis and Treatment of Primary Deep Soft Tissue Sarcomas

INGO ALLDINGER, QIN YANG, ANDREAS GOCHT, ANDREAS RAFFEL, WOLFRAM T. KNOEFEL and MATTHIAS PEIPER
Anticancer Research July 2007, 27 (4C) 2759-2764;
INGO ALLDINGER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
QIN YANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS GOCHT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS RAFFEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WOLFRAM T. KNOEFEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATTHIAS PEIPER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: matthias.peiper@uni-duesseldorf.de
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The objective of this study was to define the prognostic factors for survival of patients with soft tissue sarcomas (STS) of the extremities located below the muscular fascia. Patients and Methods: One hundred and twenty-seven consecutive patients, resected in our Institution between March 1988 and December 2002, were reviewed. Results: On univariate analysis, the prognostic factors for survival were tumor size, nodal status, adequate surgery, tumor malignancy grade and administered chemotherapy. Additionally, local failure, metastasis after resection and residual tumor after incomplete resection followed by complete resection were adverse prognostic factors for survival. The tumor size, nodal status and metastasis after resection were factors indicating worse survival on multivariate analysis. Conclusion: Our results indicate that most factors influencing the course of the disease cannot be controlled by the surgeon. Complete resection is imperative for local control and allows the patient the chance of a cure. New treatment procedures should be evaluated in prospective trials to optimize therapy. Surgery without sufficient information on the malignancy or expansion of the tumor might be detrimental for the patient.

  • Soft tissue sarcoma
  • subfascial
  • surgery
  • compartment resection
  • survival

Footnotes

  • ↵# Current address: Klinik für Allgemein-, Viszeral- und Kinderchirurgie Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany

  • Received November 28, 2006.
  • Revision received March 5, 2007.
  • Accepted March 9, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (4C)
Anticancer Research
Vol. 27, Issue 4C
July-August 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognosis and Treatment of Primary Deep Soft Tissue Sarcomas
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
14 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognosis and Treatment of Primary Deep Soft Tissue Sarcomas
INGO ALLDINGER, QIN YANG, ANDREAS GOCHT, ANDREAS RAFFEL, WOLFRAM T. KNOEFEL, MATTHIAS PEIPER
Anticancer Research Jul 2007, 27 (4C) 2759-2764;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognosis and Treatment of Primary Deep Soft Tissue Sarcomas
INGO ALLDINGER, QIN YANG, ANDREAS GOCHT, ANDREAS RAFFEL, WOLFRAM T. KNOEFEL, MATTHIAS PEIPER
Anticancer Research Jul 2007, 27 (4C) 2759-2764;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
  • Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
  • Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2022 Anticancer Research

Powered by HighWire